STAA Q2 2020 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q2 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$35M-11.3% YoY

Gross Profit

$24M69.4% margin

Operating Income

-$1M-3.0% margin

Net Income

-$1M-3.3% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$17,000

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$218M

Total Liabilities

$43M

Stockholders' Equity

$175M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$40M	-11.3%
Gross Profit	$24M	$30M	-18.3%
Operating Income	-$1M	$5M	-122.9%
Net Income	-$1M	$4M	-129.9%

Revenue Segments

Implantable Collamer Lenses

$31M87%

Intraocular Lenses

$3M7%

Other Surgical Products

$2M5%